Tuberculosis & Infectious Lung Disease
Pulmonary Tuberculosis: What Every Patient and Family in Pakistan Needs to Know
Pakistan carries one of the highest tuberculosis burdens in the world, and yet stigma, incomplete treatment, and delayed diagnosis remain the norm rather than the exception. A pulmonologist explains how TB actually spreads, how it is diagnosed and treated today, and why finishing the full course of treatment matters more than almost anything else in respiratory medicine.
Dr. Nabila Zaheer Pulmonologist & Respiratory Specialist
Published June 30, 2026
Read time 13 min
A young man in his early thirties came to my clinic after three weeks of a persistent cough, drenching night sweats that soaked through his clothes, and a weight loss he had not been trying to achieve. He had assumed it was a stubborn chest infection and had already completed two separate courses of antibiotics from a local pharmacy, neither of which helped. By the time he reached me, he was visibly thin, exhausted, and frightened — not of the diagnosis itself, but of what people would think of him once they knew.
His chest X-ray and sputum test confirmed pulmonary tuberculosis. He recovered fully — TB is, in the vast majority of cases, a completely curable disease — but his story illustrates two problems I see constantly in practice. The first is diagnostic delay: TB symptoms are non-specific enough that they are frequently treated as ordinary infections for weeks before anyone considers testing for tuberculosis. The second is stigma, which causes patients to hide their diagnosis, delay seeking care, and sometimes abandon treatment partway through out of shame or fear of how family, employers, or neighbours will react.
Both problems are addressable with clear, accurate information. This article explains what TB actually is, how it spreads, what modern treatment involves, and why completing that treatment — even after you start feeling better — is one of the most important things a patient can do, both for themselves and for the people around them.
10.6 million people develop active TB disease globally each year — making it one of the world's leading infectious causes of death
Pakistan ranks among the 5 highest TB-burden countries in the world, with hundreds of thousands of new cases diagnosed annually
95%+ cure rate for drug-sensitive TB when the full prescribed treatment course is completed correctly
What Is Tuberculosis?
Tuberculosis is a bacterial infection caused by Mycobacterium tuberculosis, most commonly affecting the lungs (pulmonary TB) but capable of affecting almost any organ in the body, including the lymph nodes, spine, kidneys, and brain (extrapulmonary TB). It spreads through the air when a person with active pulmonary TB coughs, sneezes, speaks, or sings, releasing tiny droplets containing the bacteria that can be inhaled by people nearby.
An important distinction that confuses many patients is the difference between TB infection and TB disease. When a person inhales the bacteria, their immune system usually contains it, walling it off in a dormant state — this is called latent TB infection. A person with latent TB feels completely well, has no symptoms, and cannot spread the infection to others. In roughly five to ten percent of infected individuals, the bacteria eventually overcome the immune system's containment and multiply, causing active TB disease — the form that produces symptoms and is contagious through the airborne route. This can happen within months of infection or, in some cases, many years later, particularly if the immune system is weakened by illness, malnutrition, diabetes, HIV, or certain medications.
Pakistan's very high TB burden reflects a combination of factors: dense urban populations facilitating airborne spread, widespread undiagnosed latent infection in the community, malnutrition, diabetes (which significantly increases TB risk), limited access to diagnostic services in some areas, and historically inconsistent treatment completion that has allowed drug-resistant strains to emerge in a meaningful minority of cases.
How TB Actually Spreads — and What Does Not Spread It
Understanding the actual transmission route of TB helps dismantle much of the unnecessary fear and stigma surrounding the disease. TB spreads almost exclusively through prolonged, close airborne contact with someone who has active, untreated pulmonary TB — not through casual contact, shared utensils, handshakes, or surfaces.
🫁
Sustained close contact is what matters
The people at meaningful risk of catching TB from an infected person are those who share an enclosed space with them for many hours — household members, close coworkers in confined settings, or fellow residents of crowded housing. Brief, casual contact, such as sitting near someone on a bus once, carries minimal risk.
💊
Treatment rapidly reduces infectiousness
A person with active TB who begins appropriate treatment typically becomes substantially less infectious within two to three weeks, even though the full treatment course continues for months. This is one of the most important facts for patients and families to understand — the period of meaningful contagion risk is much shorter than the total treatment duration.
🚫
What does not spread TB
TB does not spread through shaking hands, sharing food or drink, sharing clothing or bedding, toilet seats, or casual social contact. Families and friends of TB patients face no risk from these everyday interactions, and avoiding someone undergoing treatment serves no protective purpose while causing significant unnecessary social harm.
😴
Latent TB cannot spread to others
A person with latent TB infection — the dormant, asymptomatic form — is not infectious and poses no risk to family members, coworkers, or anyone else, regardless of how close the contact is. Only active disease, with bacteria present in the airways and typically visible on sputum testing, is transmissible.
Recognising the Symptoms of Active TB
The classical symptoms of pulmonary TB develop gradually over weeks, which is part of why diagnosis is so often delayed — patients and even clinicians initially attribute the symptoms to a routine respiratory infection. Any combination of the following symptoms persisting for more than two to three weeks should prompt TB testing, particularly in a country with Pakistan's disease burden.
Symptoms That Warrant TB Testing
- A cough lasting more than two to three weeks, with or without sputum production — the single most important symptom to act on, regardless of how mild it initially seems.
- Coughing up blood or blood-streaked sputum (haemoptysis) — always warrants urgent evaluation, as it can indicate TB or other serious lung conditions.
- Drenching night sweats — severe enough to soak nightclothes or bedding, distinct from ordinary warm-weather sweating.
- Unintentional weight loss — occurring without dieting or increased physical activity.
- Low-grade fever, often more noticeable in the evenings, that persists for weeks rather than resolving as an ordinary infection would.
- Loss of appetite and persistent fatigue that does not improve with rest.
- Chest pain, particularly pain that worsens with breathing or coughing.
The single biggest delay I see in TB diagnosis is patients — and sometimes their initial doctors — treating a persistent cough as an ordinary chest infection for weeks before anyone considers testing for TB. In a country with Pakistan's TB burden, any cough lasting beyond two to three weeks deserves a chest X-ray and sputum test as a matter of routine, not as a last resort after several rounds of antibiotics have already failed. Earlier diagnosis means a shorter, simpler treatment course and far less time during which the patient could unknowingly expose people close to them.
— Dr. Nabila Zaheer, Pulmonologist
How TB Is Diagnosed
Sputum smear microscopy
A sample of sputum is examined under a microscope for the presence of acid-fast bacilli — a rapid, widely available test that remains the backbone of TB diagnosis in Pakistan's public health system. It is quick and inexpensive but can miss cases with a lower bacterial load, so a negative result does not always rule out TB when clinical suspicion remains high.
GeneXpert (molecular testing)
A rapid molecular test that detects TB bacterial DNA directly from a sputum sample, typically providing results within two hours. It is significantly more sensitive than smear microscopy and, critically, simultaneously tests for resistance to rifampicin, one of the key first-line drugs — making it invaluable for identifying drug-resistant TB early. GeneXpert is now widely available across major centres in Pakistan and is the preferred initial test wherever accessible.
Chest X-ray
Classic findings in pulmonary TB include upper lobe infiltrates, cavities, and scarring, though the appearance can vary considerably, particularly in patients with weakened immune systems. A chest X-ray is essential both for initial diagnosis and for monitoring treatment response over time.
Sputum culture
The gold standard diagnostic test, growing the bacteria from a sputum sample over several weeks. Although slower than other methods, culture allows full drug susceptibility testing across all anti-TB medications and remains essential, particularly when drug resistance is suspected or when initial rapid tests are inconclusive.
Tuberculin skin test and interferon-gamma release assays
These tests identify whether a person has been infected with TB at any point, distinguishing infection from active disease requires correlation with symptoms and imaging. They are most useful for diagnosing latent TB infection in contacts of active cases, rather than for diagnosing active disease itself.
TB Treatment: What the Full Course Actually Involves
The treatment of drug-sensitive pulmonary TB follows a standardised regimen that has remained highly effective for decades when followed correctly. Understanding the structure of treatment — and why every part of it matters — significantly improves the likelihood of completing it successfully.
The Standard Six-Month Regimen
The standard first-line treatment consists of four drugs — isoniazid, rifampicin, pyrazinamide, and ethambutol — taken together for an intensive phase of two months, followed by isoniazid and rifampicin alone for a continuation phase of four months, for a total treatment duration of six months. This combination of multiple drugs is essential: using a single drug, or stopping treatment early, allows surviving bacteria with natural resistance to multiply, which is precisely how drug-resistant TB strains develop.
Why Stopping Early Is the Single Biggest Risk in TB Treatment
Most patients begin to feel significantly better within two to four weeks of starting treatment — the cough improves, energy returns, fever resolves. This is exactly the point at which the temptation to stop treatment, whether due to feeling cured, medication side effects, cost, or simply the inconvenience of continuing, becomes strongest. Stopping early is the single most important preventable cause of treatment failure, relapse, and — critically — the development of multidrug-resistant TB (MDR-TB), a far more difficult and prolonged condition to treat. Feeling better is not the same as being cured. The full six months exists because that is what is required to eliminate the bacterial population completely, including more slowly dividing organisms that survive the initial weeks of treatment.
Directly Observed Treatment
Given how critical treatment completion is, many TB programmes — including Pakistan's national TB control programme — use directly observed treatment (DOT), where a healthcare worker or trained community volunteer watches the patient take each dose. This is not a matter of distrust; it is a recognised, evidence-based strategy that significantly improves completion rates and is offered as routine support rather than punitive monitoring.
Managing Side Effects
The TB medications can cause side effects including nausea, loss of appetite, and in some cases liver inflammation, which is why liver function is typically monitored during treatment, particularly in the first two months. Visual changes can occur with ethambutol and should be reported promptly. Most side effects are manageable without stopping treatment, and patients should always discuss side effects with their treating physician rather than stopping medication independently — an adjusted regimen is almost always preferable to an incomplete one.
Drug-Resistant TB
When TB bacteria are resistant to at least isoniazid and rifampicin, the condition is classified as multidrug-resistant TB, requiring a longer, more complex treatment regimen using second-line drugs, typically lasting nine months to two years depending on the specific resistance pattern and regimen used. MDR-TB is more difficult to treat, more expensive, and carries lower cure rates than drug-sensitive disease — which is precisely why preventing it through complete, correctly supervised first-line treatment is so important at a population level, not just for the individual patient.
Nutrition and Supportive Care During Treatment
TB is closely linked with malnutrition in both directions — malnutrition weakens the immune system and increases susceptibility to active disease, while active TB itself increases nutritional demands and frequently causes significant weight loss. Adequate nutrition during treatment supports immune recovery, helps the body tolerate medication, and is an important, often under-addressed component of comprehensive TB care, alongside the antibiotic regimen itself. Patients should be encouraged to eat a protein-rich, calorie-adequate diet throughout treatment, and nutritional assessment should be part of routine TB care, particularly in patients who are already underweight at diagnosis.
Frequently Asked Questions
Is TB the same as cancer or a death sentence?
No. Pulmonary TB is a bacterial infection, not cancer, and with correct diagnosis and complete treatment, drug-sensitive TB is curable in well over ninety-five percent of cases. The disease carries significant stigma in many communities, partly rooted in historical eras before effective antibiotics existed, but modern TB treatment is highly effective. The most important predictor of a good outcome is completing the prescribed treatment course in full.
Can I go to work or school while being treated for TB?
This depends on the stage of treatment and the specific clinical situation, and should be discussed directly with your treating physician. As a general principle, infectiousness drops substantially within two to three weeks of starting appropriate treatment, after which the risk to others becomes very low, but the precise timing of returning to normal activities should be individually assessed rather than assumed. Do not make this decision independently — ask your doctor specifically.
My family member has TB. Do I need to be tested?
Yes — household members and other close contacts of a person with active pulmonary TB should be screened, typically with a chest X-ray and, where indicated, a test for latent TB infection. This is standard practice and is offered through TB treatment programmes specifically because close contacts carry meaningfully elevated risk of having either latent or active infection themselves. Being screened is a precautionary, routine step, not an indication that something is already wrong.
If I have latent TB and no symptoms, do I still need treatment?
In many cases, yes. While latent TB itself is not contagious and causes no symptoms, a proportion of people with latent infection will go on to develop active disease, particularly within the first two years after infection or if their immune system later becomes compromised by illness, diabetes, or certain medications. Preventive treatment for latent TB, using a shorter course of one or two drugs, substantially reduces this future risk. Your pulmonologist will assess your specific risk factors to determine whether preventive treatment is recommended for you.
Why do I need to keep taking medication for six months if I already feel better?
Because feeling better reflects a reduction in the actively multiplying bacterial population, not its complete elimination. Slower-dividing bacteria can persist for months despite symptom resolution, and stopping treatment early allows these survivors — often including any that carry natural drug resistance — to multiply again, causing relapse and significantly increasing the risk of developing drug-resistant TB. The full prescribed duration exists specifically to prevent this outcome, and is one of the most evidence-based aspects of the entire treatment protocol.
Can TB come back after successful treatment?
Relapse after a properly completed full treatment course is uncommon but can occur, particularly in patients with ongoing risk factors such as poorly controlled diabetes, malnutrition, or immune suppression. Any TB symptoms recurring after treatment completion — persistent cough, night sweats, weight loss — should prompt prompt re-evaluation rather than being dismissed, even years after the original successful treatment.
Recommended Products for TB Patients and Household Contacts
Based on my experience as a pulmonologist, these are products that can genuinely support patients undergoing TB treatment and the family members caring for them:
- N95 Respirator Masks — recommended for household members during the initial weeks of treatment when infectiousness is highest, particularly in shared living spaces with limited ventilation, providing meaningful added protection during this period.
👉 Check on Amazon Pakistan / Amazon.in - Pulse Oximeter — useful for monitoring oxygen saturation in patients with more extensive lung involvement, helping track recovery and flag any concerning changes for discussion at follow-up appointments.
👉 Check on Amazon Pakistan / Amazon.in - Nutritional Protein Supplement Powder — supports the increased nutritional demands of TB treatment and recovery, particularly valuable for patients who have experienced significant weight loss before diagnosis.
👉 Check on Amazon Pakistan / Amazon.in
Affiliate Disclosure: As an Amazon Associate, I earn from qualifying purchases. I only recommend products I believe are helpful for my patients.
A Cough That Has Lasted More Than Three Weeks Deserves an Answer, Not Another Round of Antibiotics.
If you or someone in your family has a persistent cough, night sweats, unexplained weight loss, or has been in close contact with someone diagnosed with TB, prompt testing makes treatment simpler and protects the people around you. Book a consultation with Dr. Nabila Zaheer at PulmoCare today.
Medical Disclaimer: This article is written for general informational and educational purposes only. It does not constitute medical advice and should not replace a consultation with a qualified healthcare professional. If you are experiencing symptoms described in this article, please seek evaluation from a licensed physician. Dr. Nabila Zaheer is a board-certified pulmonologist at PulmoCare, Rawalpindi — click here to book a consultation.